Facebook tracking pixel
S10.AI
ICD-10-CM · M17.0GeneralSystemic

Bilateral Osteoarthritis of the Knees

Understanding Bilateral Osteoarthritis of the Knees: Find information on Bilateral Knee OA, including diagnosis, treatment, and medical coding for Degenerative Joint Disease of Both Knees. This resource covers clinical documentation best practices for healthcare professionals and explores symptoms, causes, and management of Bilateral Osteoarthritis. Learn about Knee OA and its impact on patient care.

Also known as
Bilateral Knee OADegenerative Joint Disease of Both Knees
Definition

Degenerative cartilage breakdown in both knees causing pain and stiffness.

Clinical signs

Knee pain, stiffness, swelling, crepitus, limited range of motion, difficulty walking.

Common settings

Primary care, orthopedics, rheumatology, physical therapy, pain management.

Related Codes

ICD-10 Code Families

Complete code families applicable to M17.0

M17.0
Bilateral primary osteoarthritis knee
M17.1
Bilateral secondary osteoarthritis knee
M15-M19
Arthroses
M00-M99
Diseases of the musculoskeletal system
Code Comparison

When to use each related code

DescriptionWhen to use
Bilateral knee osteoarthritisDegenerative joint changes in both knees confirmed by imaging or clinical exam.
Unilateral knee osteoarthritisOsteoarthritis affecting only one knee, specify left or right. Use when only one knee is affected.
Generalized osteoarthritisOsteoarthritis affecting multiple joints including knees. Use when more widespread than just the knees.
Documentation

Best-practice checklist

  • Document severity & laterality of knee OA
  • Note symptom duration, onset, characteristics
  • Specify functional limitations & impact on ADLs
  • Include radiographic findings confirming OA
  • Record any prior treatments & their effectiveness
Coding & Audit Risks

Common pitfalls to avoid

Laterality Specificity

Coding requires distinct codes for bilateral OA or separate codes for each knee if different stages. Missing laterality can lead to undercoding or overcoding.

Severity Documentation

Unspecified OA severity impacts reimbursement. Clinical documentation must specify mild, moderate, or severe OA for accurate code assignment.

Associated Conditions

Pain management, joint injections, or other related conditions should be documented and coded separately to reflect the full scope of care.

Mitigation

Best-practice tips

  • 01Code accurately: M17.0 for bilateral knee OA. Document severity.
  • 02CDI: Specify laterality, affected joint compartments, and pain level.
  • 03Comply with coding guidelines. Avoid unspecified codes like M19.90.
  • 04Document functional limitations and impact on daily activities.
  • 05Support medical necessity for interventions with clear documentation.
Clinical Decision Support

Step-by-step checklist

  1. 1

    Confirm radiographic evidence of OA in both knees (e.g., Kellgren-Lawrence grade)

  2. 2

    Document pain and stiffness in both knees impacting daily activities

  3. 3

    Assess range of motion limitations in both knees

  4. 4

    Evaluate for crepitus, tenderness, and joint effusion in both knees

Documentation Template

Ready-to-paste narrative

Patient presents with complaints of bilateral knee pain consistent with osteoarthritis.  The patient reports chronic, aching pain in both knees, exacerbated by weight-bearing activities and prolonged standing.  Symptoms include stiffness, particularly in the morning or after periods of inactivity, crepitus with movement, and reduced range of motion.  The patient denies any history of acute trauma to either knee.  Physical examination reveals palpable bony crepitus in both knees, mild joint effusion bilaterally, and tenderness to palpation along the joint lines.  McMurray's test is negative for meniscal tears.  Radiographic imaging of both knees demonstrates characteristic findings of osteoarthritis, including joint space narrowing, osteophyte formation, and subchondral sclerosis.  Diagnosis of bilateral knee osteoarthritis is confirmed.  Treatment plan includes conservative management with non-steroidal anti-inflammatory drugs (NSAIDs) for pain management, physical therapy to improve range of motion and strengthen supporting musculature, and weight management counseling.  Patient education provided on joint protection strategies and the importance of regular exercise.  Follow-up scheduled in four weeks to assess response to treatment and discuss further management options if necessary, including viscosupplementation or referral to orthopedics for surgical intervention.  Differential diagnoses considered included rheumatoid arthritis and meniscal injury, but ruled out based on clinical presentation and imaging findings.  ICD-10 code M17.0 assigned for bilateral primary osteoarthritis of the knee.
FAQs

Common questions and answers

What are the best evidence-based non-surgical treatment options for managing bilateral knee osteoarthritis pain and stiffness in elderly patients with comorbidities?+

Managing bilateral knee osteoarthritis in elderly patients with comorbidities requires a multifaceted approach prioritizing non-surgical interventions. Evidence-based treatments include weight management, tailored exercise programs focusing on strengthening and range of motion (e.g., low-impact aerobics, aquatic therapy), and the use of assistive devices like canes or walkers to reduce joint loading. Pharmacological options include topical and oral analgesics such as NSAIDs (with careful consideration of cardiovascular and renal risks), acetaminophen, and duloxetine. Intra-articular injections of corticosteroids or hyaluronic acid can provide temporary relief. Consider implementing a combination of these strategies based on patient-specific factors and comorbidities. Explore how incorporating patient education on self-management techniques can enhance treatment efficacy and improve quality of life. For cases refractory to conservative measures, referral to an orthopedist for surgical evaluation may be necessary.

How do I differentiate between bilateral knee osteoarthritis and other inflammatory arthritides, such as rheumatoid arthritis, during the initial clinical evaluation and diagnostic workup?+

Differentiating bilateral knee osteoarthritis from inflammatory arthritides like rheumatoid arthritis requires a thorough clinical assessment. While both present with pain and stiffness, osteoarthritis typically involves morning stiffness lasting less than 30 minutes, crepitus on joint examination, and bony enlargement. Inflammatory arthritides, on the other hand, often exhibit prolonged morning stiffness exceeding one hour, symmetrical joint involvement, warmth, and tenderness to palpation. Laboratory tests such as rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP) antibodies, and erythrocyte sedimentation rate (ESR) can help distinguish between osteoarthritis and inflammatory conditions. Imaging studies, including X-rays, are crucial for identifying characteristic osteoarthritic changes like joint space narrowing, osteophytes, and subchondral sclerosis. Consider incorporating advanced imaging techniques such as MRI if the diagnosis remains uncertain. Learn more about specific inflammatory markers and imaging protocols for a comprehensive diagnostic workup.

What are the latest guidelines and best practices for using viscosupplementation injections (e.g., hyaluronic acid) for bilateral knee osteoarthritis, and when should I consider this treatment option for my patients?+

Viscosupplementation with hyaluronic acid is a treatment option for bilateral knee osteoarthritis, particularly in patients who have not adequately responded to conservative measures like exercise and physical therapy. Current guidelines recommend considering viscosupplementation for patients with mild to moderate osteoarthritis who have not achieved sufficient pain relief with non-pharmacological and simple analgesic therapies. It is essential to assess patient-specific factors, such as the severity of symptoms, presence of comorbidities, and previous treatment responses. While viscosupplementation can provide temporary pain relief and improve joint function in some patients, its long-term efficacy remains debated. Explore how combining viscosupplementation with other non-surgical modalities can optimize outcomes. Consider implementing shared decision-making with your patients to ensure they understand the potential benefits, risks, and limitations of this treatment option.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.